An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue SUPPL. C, 1996, Pages 63-69

  Rodriguez, A F ^a  

^a Hospital Infantil Juan Pablo II   (Guatemala)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ENTERITIS; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; RANDOMIZED CONTROLLED TRIAL; RASH; RELAPSE; SYMPTOM;

EID: 0029812774     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.suppl_c.63     Document Type: Article

References (24)

1. Aronoff, S. C., Laurent, C. & Jacobs, M. R. (1987). In-vitro activity of erythromycin, roxithromycin and CP-62,993 against common paediatric pathogens. Journal of Antimicrobial Chemotherapy 19, 275-6.
2. Bergman, A. B. & Werner, R. J. (1963). Failure of children to receive penicillin by mouth. New England Journal of Medicine 268, 1334-8.
3. Bright, G. M., Nagel, A. A., Bordner, J., Desai, K. A., Dibrino, J. N., Nowakowska, J. el al. (1988). Synthesis, in vitro and in rivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives: a new class of macrolide antibiotics, the azalides. Journal of Antibiotics 41, 1029-47.
4. Bluestone, C. D. (1990). Rationale for antimicrobial therapy of otitis media. In Update on Otitis Media. International Congress and Symposium Series (Nelson, J. D., Ed.), pp. 23-32. Royal Society of Medicine, London.
5. Bulmer, J. L., Bertino, J. S. & Husak, M. P. (1984). Comparison of cefaclor and trimethoprim-sulfamethoxazole in the treatment of acute otitis media. Pediatric Infectious Diseases 3, 25-9.
6. Daniel, R. R. (1993). Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children. Journal of Antimicrobial Chemotherapy 31, Suppl. E, 65-71.
7. Dunkin, K. T., Jones, S. & Howard, A. J. (1988). The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci. Journal of Antimicrobial Chemotherapy 21, 405-11.
8. Foulds, G., Shepard, R. M. & Johnson, R. B. (1990). The pharmacokinetics of azithromycin in human serum and tissues. Journal of Antimicrobial Chemotherapy 25, Suppl. A, 73-82.
9. Géhanno, P., Boucot, I., Simonet, M., Bingen, F., Lambert-Zechovsky, N. & Berche, P. (1992). Epidemilogie bactérienne de l'otite moyenne aiguë. Annales de Pediatrie 39, 485-90.
10. Géhanno, P., Taillebe, M., Denis, P., Jacquet, P., Hoareau, J., Gojon, D. et al. (1990). Short-course cefotaxime compared with five-day co-amoxyclav in acute otitis media in children. Journal of Antimicrobial Chemotherapy 26, Suppl. A, 29-36.
11. Girard, A. E., Faiella, J. A. & Cimochowski, C. R. (1991). The unique pharmacokinetics of azithromycin in models of localized infection. In Program and Abstracts of the Fifth European Congress on Clinical Microbiology and Infectious Diseases, Oslo, 1991. Abstract 1754.
12. Hardy, D. J., Hensey, D. M., Beyer, J. M., Vojtko, C., McDonald, E. J. & Fernandes, P. B. (1988). Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrobial Agents and Chemotherapy 32, 1710-9.
13. Harrison, C. J., Marks, M. I. & Welch, D. F. (1985). Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media. Pediatric Infectious Diseases 4, 641-6.
14. Holm, V. A. & Kunze, L. H. (1969). Effects of chronic otitis media on language and speech development. Pediatrics 43, 833-9.
15. Klein, J. O. & Bluestone, C. D. (1982). Acute otitis media. Pediatric Infectious Diseases I, 66-73.
16. Lim, D. J. (1989). Recent advances in otitis media: report of the fourth research conference. Annals of Otology, Rhinology and Laryngology 98, Suppl. 139, 1-55.
17. Machka, K. (1990). Global trends in resistance of Haemophilus influenzae and Moraxella (Branhamella) catarrhalis. In Update on Otitis Media. International Congress and Symposium Series (Nelson, J. D., Ed.), pp. 15-21. Royal Society of Medicine, London.
18. Mohs, E., Roderigues-Solares, A., Rivas, E. & El Hoshy, Z. (1993). A comparative study of azithromycin and amoxycillin in paediatric patients with acute otitis media. Journal of Antimicrobial Chemotherapy 31, Suppl. E, 73-9.
19. Pestalozza, G., Cioce, C. & Facchini, M. (1992). Azithromycin in upper respiratory tract infections: a clinical trial in children with otitis media. Scandinavian Journal of Infectious Diseases 83, 22-5.
20. Pukander, J. & Rautianen, M. (1996). Penetration of azithromycin into middle ear effusions in acute and secretory otitis media in children. Journal of Antimicrobial Chemotherapy 37, Suppl. C, 53-61.
21. Retsema, J., Girard, A., Schelkly, W., Manousos, M., Anderson, M., Bright, G. et al. (1987). Spectrum and mode of action of azithromycin (CP-62, 993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrobial Agents and Chemotherapy 31, 1939-47.
22. Schaad, U. B. (1993). Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children. Journal of Antimicrobial Chemotherapy 31, Suppl. E, 81-8.
23. Teele, D. W., Klein, J. O. & Rosner, B. A. (1984). Otitis media with effusion during the first three years of life and the development of speech and language. Pediatrics 74, 282-7.
24. Washington, J. A. & Wilson, W. R. (1985). Erythromycin: a microbial and clinical perspective after 30 years of clinical use. Part 2. Mayo Clinic Proceedings 60, 271-8.